Effect of sodium-glucose transport protein 2 inhibitors on all-cause mortality in patients with gout: A multi-center cohort study

被引：0

作者：

Chan, Shu-Yen ^{[1
,2
,3
]}

Ma, Kevin Sheng-Kai ^{[2
,4
,5
]}

机构：

[1] Weiss Mem Hosp, Dept Internal Med, Chicago, IL USA

[2] Univ Penn, Perelman Sch Med, Ctr Global Hlth, Philadelphia, PA USA

[3] Taipei Med Univ, Coll Med, Dept Med, Taipei, Taiwan

[4] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2024年 / 153卷

关键词：

SGLT2; inhibitor; gout; all-cause mortality; type 2 diabetes mellitus;

D O I：

10.1016/j.metabol.2024.155887

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0095

引用

页数：3